NasdaqCM:NAGEPersonal Products
Is Niagen Bioscience’s (NAGE) NAD+ Research Push Quietly Redefining Its Competitive Moat?
Niagen Bioscience, Inc. recently renamed its ChromaDex External Research Program as the Niagen Research Program and introduced a Trainee Grant Program to support new investigators in exercise performance and recovery, extending backing to more than 175 ongoing NAD+ studies worldwide.
This refresh concentrates the company’s scientific identity squarely around its patented Niagen ingredient, underlining how deeply its brand is tied to NAD+ research collaborations.
Next, we’ll consider how this...